Breastfeeding and Childhood Obesity Among African Americans: A Systematic Review

Camber Hess1, Agatha Ofei, Alicia Mincher

  • 1Camber Hess is a family nurse practitioner at Premier Family Medical, Pleasant Grove, UT. She can be reached via e-mail at camberhess@gmail.com Agatha Ofei is a family nurse practitioner at Calvary Medical Clinic, Charlotte, NC. Alicia Mincher is a staff nurse at Cincinnati Children's hospital in Cincinnati, OH.

Insights

Breastfeeding may protect African American children from obesity. More research is needed, but current evidence suggests a benefit, highlighting the need for healthcare providers to discuss breastfeeding with African American women.

Area of Science:

  • Public Health
  • Pediatrics
  • Nutrition

Background:

  • African Americans experience lower breastfeeding rates and higher obesity rates compared to other US ethnicities.
  • Childhood obesity is a significant public health concern with long-term health implications.

Purpose of the Study:

  • To systematically review the correlation between breastfeeding practices and childhood obesity among African Americans in the United States.
  • To synthesize existing evidence on the impact of breastfeeding on obesity risk in this specific demographic.

Main Methods:

  • Systematic review of studies identified through CINAHL, PubMed, and Google Scholar.
  • Inclusion criteria focused on studies examining breastfeeding and childhood/adolescent obesity in African Americans.
  • Twelve observational studies met the inclusion criteria.

Main Results:

  • Eight of the twelve observational studies indicated a protective effect of breastfeeding against childhood obesity in African Americans.
  • Four studies yielded inconclusive results regarding the association.
  • No randomized-controlled trials or meta-analyses were identified.

Conclusions:

  • Current evidence suggests a potential protective effect of breastfeeding against childhood obesity in the African American population.
  • Limitations include the observational nature of studies and the inclusion of other ethnicities.
  • Further research is necessary to generalize findings; healthcare providers should address breastfeeding benefits and barriers.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.6K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
341
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
284
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
385
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
804